Correlation Between LumiraDx and Trinity Biotech

Can any of the company-specific risk be diversified away by investing in both LumiraDx and Trinity Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LumiraDx and Trinity Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LumiraDx and Trinity Biotech plc, you can compare the effects of market volatilities on LumiraDx and Trinity Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LumiraDx with a short position of Trinity Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of LumiraDx and Trinity Biotech.

Diversification Opportunities for LumiraDx and Trinity Biotech

0.0

Correlation Coefficient

LumiraDx  Trinity Biotech

Pay attention - limited upside

The 3 months correlation between LumiraDx and Trinity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding LumiraDx and Trinity Biotech plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trinity Biotech plc and LumiraDx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LumiraDx are associated (or correlated) with Trinity Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trinity Biotech plc has no effect on the direction of LumiraDx i.e., LumiraDx and Trinity Biotech go up and down completely randomly.

Pair Corralation between LumiraDx and Trinity Biotech

If you would invest (100.00) in LumiraDx on December 29, 2024 and sell it today you would earn a total of  100.00  from holding LumiraDx or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

LumiraDx  vs.  Trinity Biotech plc

LumiraDx

Risk-Adjusted Performance

Very Weak

Over the last 90 days LumiraDx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, LumiraDx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Trinity Biotech plc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Trinity Biotech plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Trinity Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with LumiraDx and Trinity Biotech

The main advantage of trading using opposite LumiraDx and Trinity Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LumiraDx position performs unexpectedly, Trinity Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trinity Biotech will offset losses from the drop in Trinity Biotech's long position.

The idea behind LumiraDx and Trinity Biotech plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.